Pralidoxime is used in the treatment of organophosphate poisoning, often in conjunction with atropine and supportive therapy. Pralidoxime is only marginally absorbed after oral dosing and oral dosage forms are no longer available in the United States.
Storage/Stability: Unless otherwise instructed by the manufacturer, pralidoxime chloride powder for injection should be stored at room temperature. After reconstituting with sterile water for injection, the solution should be used within a few hours. Do not use sterile water with preservatives added.